The rising interest in GLP-1 agonists for diabetes has led to a debate about application forms : skin-applied devices versus tablets . Traditionally , GLP-1 drugs were solely available in pill form, but the https://rajanoaoz250886.blogtov.com/21638660/glp-1-transdermal-delivery-systems-vs-tablets-is-right-for-individuals